Struggling Rockville biotech brings in new CEO to explore 'strategic options'
The new leader has a history of taking over distressed companies and, in some cases, finding buyers for them. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 26, 2024 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news

Pharma companies bet on flagship products to grow in strength
Indian drug manufacturers are utilizing flagship products or "mother brands" to introduce new combinations and establish leadership in therapy areas, as per research by Pharmarack. For example, USV's anti-diabetes drug Glycomet has bolstered the company's reputation in diabetic therapy and facilitated partnerships with multinational drugmakers for innovative therapies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 26, 2024 Category: Pharmaceuticals Source Type: news

Roche receives FDA approval for the first molecular test to screen for malaria in blood donors
The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malariaMalaria is a serious and potentially fatal parasitic infection most commonly transmitted by mosquitoes that can also be spread through blood transfusionRoche is dedicated to saving patients ’ lives through diagnostic solutions that aid in the protection of the global blood supply from infectious diseasesBasel, 26 March 2024  - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. Food and Drug Administration (FDA) approval of the cobas® Malaria test for use on the cobas® 6800/8800 Systems. This approved test ca...
Source: Roche Investor Update - March 26, 2024 Category: Pharmaceuticals Source Type: news

Cipla to distribute Sanofi's CNS product line in India
According to the joint statement, Cipla will utilise its skills and solid India-wide network of distributors, institutions and market outreach programmes to expand access to these treatments for patients. Meanwhile, Sanofi India will continue to own, import, and manufacture its entire range of CNS products across plants in India and abroad. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 26, 2024 Category: Pharmaceuticals Source Type: news

Spirit headquarters office park 98% leased
Pair of companies signed new deals at the 600-acre industrial campus. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 26, 2024 Category: Biotechnology Authors: Erik Bojnansky Source Type: news

Smallpox may be gone but U.S. should better prepare for its return, report says
Nearly 5 decades after the last documented case, smallpox remains the only human disease that has been officially eradicated. But a new report concludes that the United States can do much to strengthen its ability to respond if the dreaded disease resurfaces, whether naturally, through a lab “leak” of the responsible virus, or from an act of terrorism. The authors of the smallpox report, however, do not offer a recommendation on the long-running debate over whether the only two labs that still hold samples of variola, the smallpox virus, should destroy them for safety reasons—that issue was outside th...
Source: ScienceNOW - March 26, 2024 Category: Science Source Type: news

Wicked Sheets among local companies to receive National Institutes of Health funding in FY2023
Research funding from the National Institutes of Health (NIH) generated $92.9 billion in new economic activity nationwide last year, according to a news release from industry group United for Medical Research (UMR). (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 26, 2024 Category: Biotechnology Authors: David A. Mann Source Type: news

Whitman-Walker appoints new health system CEO
The new chief takes over after a year of interim leadership. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 26, 2024 Category: Biotechnology Authors: Sara Gilgore Source Type: news

Meet Paola Delp, a 2024 BusinessWoman of the Year honoree
Paola Delp is the president of CareNu and a 2024 BusinessWoman of the Year honoree. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 26, 2024 Category: Biotechnology Authors: Chris Erickson Source Type: news

Going beyond blood glucose monitoring: How CGM's panoramic perspective redefines diabetes management
ICMR-INDIAB study shows 44% rise in diabetes cases to over 101 million. CGM technology plays a crucial role in managing Type 2 diabetes by providing real-time monitoring and actionable insights, ultimately improving glucose control and reducing health complications. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 26, 2024 Category: Pharmaceuticals Source Type: news

Viking Surges After Weight-Loss Pill Tops Expectations In Just 28 Days
Viking stock gapped up Tuesday after the biotech company's oral weight-loss drug beat expectations in a 28-day study. The post Viking Surges After Weight-Loss Pill Tops Expectations In Just 28 Days appeared first on Investor's Business Daily. (Source: Reuters: Health)
Source: Reuters: Health - March 26, 2024 Category: Consumer Health News Source Type: news

Weight loss drugs firm expands into heart disease treatment
The Nova Nordisk deal is due to be wrapped up in the second quarter of this year. It will help establish the maker of Wegovy and Ozempic in the cardiovascular treatment market. Pharmaceutical giant Novo Nordisk is to take over German biotech company Cardior Pharmaceuticals in a deal worth up to…#novanordisk #wegovyandozempic #novonordisk #novo #cardior #rna #martinholstlange #cdr132l #claudiaulbrich #elililly (Source: Reuters: Health)
Source: Reuters: Health - March 26, 2024 Category: Consumer Health News Source Type: news

Daughter of refugees founded a biotech to combat diseases that have afflicted her family
From the San Francisco Business Times. For Hanadie Yousef, the inspiration for pushing Juvena Therapeutics ’ aging-related drug toward its first clinical trial is never far away. Her father, Anwar Yousef, grew up in a United Nations-administered refugee camp in Jordan. He taught himself English and escaped war and poverty by earning one of two scholarships in Jordan awarded by the British Council, a nondepartmental public body sponsored by the government, to Oxford University. After finishing… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 26, 2024 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Trial results for Dravet drug spurs stock surge at Bedford biotech
Stoke Therapeutics, which develops RNA-altering drugs for rare diseases, announced what it called “landmark” results from an early-stage trial of a drug for a rare, debilitating form of epilepsy that affects children. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 26, 2024 Category: Pharmaceuticals Authors: Don Seiffert Source Type: news

AdventHealth celebrates topping out of medical center in Palm Coast
Robins& Morton is the construction firm on the two-story, 30,000-square-foot standalone facility. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 26, 2024 Category: Biotechnology Authors: Stuart Korfhage Source Type: news